Ledger.Open graph →
SEC Form D · filed June 30, 2015

Gladius Pharmaceuticals Corp

Offering
$728K
Sold
$728K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Michael Atkin · Wilmington, DEExec · DirectorAnne S. Walsh · Santa Monica, CAExec · DirectorJim Dauwalter · Golden Valley, MNExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗